Medicine and Dentistry
Patient
100%
Allergic Encephalitis
54%
Association
47%
White Matter
37%
Encephalitis
30%
Apoplexy
27%
Basilar Artery
26%
Artery Occlusion
25%
Epileptic Seizure
24%
Modified Rankin Scale
23%
Magnetic Resonance Imaging
22%
Evaluation Study
20%
Symptom
19%
Inpatient
19%
Brain
19%
Immunotherapy
19%
Placebo
17%
Age
17%
Combination Therapy
16%
National Institutes of Health Stroke Scale
16%
Development
14%
Disease
14%
Epilepsy
14%
Disease Exacerbation
14%
Follow up
14%
Lesion
14%
Rituximab
13%
Meningoencephalitis
13%
Cerebrovascular Disease
13%
Moyamoya Disease
13%
Tocilizumab
13%
Cognition
13%
Small Vessel Disease
13%
Digital Subtraction Angiography
13%
Obstructive Sleep Apnea
13%
Immunoglobulin
13%
White Matter Lesion
13%
Adverse Event
12%
Magnetic Resonance Angiography
12%
Clinical Assessment
11%
Status Epilepticus
11%
Transcranial Doppler
11%
Adult
10%
Stenosis
9%
Memory
9%
Memory Disorder
9%
Receptor
8%
Lacune
8%
Shear Stress
8%
Depression
8%
Neuroscience
Encephalitis
51%
Seizure
27%
Brain
23%
Magnetic Resonance Imaging
22%
Epilepsy
21%
White Matter
17%
Immunotherapy
17%
Ataxia
16%
Depression
15%
Rituximab
13%
Central Nervous System
13%
Stroke
13%
Midodrine
13%
Functional Connectivity
13%
Nystagmus
13%
Tocilizumab
13%
Nilotinib
13%
Epigenetics
13%
Blood Brain Barrier
11%
Placebo
11%
Alzheimer's Disease
10%
Transcranial Doppler
9%
Status Epilepticus
8%
Memory
8%
MicroRNA
7%
Stenosis
7%
Ictogenesis
7%
Cognition
7%
Rapid Eye Movement Sleep Behavior Disorder
7%
Meningoencephalitis
7%
Intravenous Immunoglobulin
6%
Methyldienolone
6%
Dextro Aspartic Acid
6%
Pyridostigmine
6%
Dementia
6%
Spinocerebellar Ataxia
6%
Obstructive Sleep Apnea
6%
Electroencephalography
6%
Neurofilament
6%
Atomoxetine
6%
Bisoprolol
6%
Rapid Eye Movement Sleep
6%
Phenobarbital
6%
Behavior Disorder
6%
Limbic Encephalitis
6%
Angiography
6%
Transient Global Amnesia
6%
Functional Magnetic Resonance Imaging
6%
Human Leukocyte Antigen
6%
Sleep
6%
